Last reviewed · How we verify

NCT02686021: NovIbu

Potential Benefit of the Combination of Metamizole and Ibuprofen After Third Lower Molar Extraction

Completed Phase 4 Last updated 4 May 2021
What this trial tests

Phase 4 trial testing Metamizole and Ibuprofen in Pain, Postoperative in 36 participants. Completed in 28 April 2021.

Timeline
15 February 2016
Primary endpoint
28 April 2021
28 April 2021

Quick facts

Lead sponsorUniversity Hospital, Basel, Switzerland
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposetreatment
Enrollment36
Start date15 February 2016
Primary completion28 April 2021
Estimated completion28 April 2021
Sites1 location across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Basel, Switzerland

Who can join

Adults 18 to 60, any sex, with Pain, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Postoperative pain is common and particularly outpatients may experience unsatisfactory pain relief. This randomized, double-blind, crossover study of postoperative pain in outpatients undergoing split-mouth, third lower molar extraction aims to examine whether or not the combination of metamizole and ibuprofen is superior to either drug alone.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Parenteral Ready-to-Use Fixed-Dose Combinations Including NSAIDs with Paracetamol or Metamizole for Multimodal Analgesia-Approved Products and Challenges.
    Silva F, Costa G, Veiga F, Cardoso C, et al · · 2023 · cited 6× · PMID 37630999 · DOI 10.3390/ph16081084

Verify or expand the search:

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other University Hospital, Basel, Switzerland trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02686021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing